Details of the Drug Reposition

General Information of This Drug (ID: DMYHBKN)

Drug Name
Exenatide   DMYHBKN
Synonyms Exenatide Synthetic; AC 2993 LAR; Ex4 peptide; Byetta (TN); Exendin 4 (Heloderma suspectum); Extendin-4; L-Serinamide
Therapeutic Class
Hypoglycemic Agents
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Inflammation DISJUQ5T 1A00-CA43.1 Approved [1]
Type-1/2 diabetes DISIUHAP 5A10-5A11 Approved [1]
Non-insulin dependent diabetes DISK1O5Z 5A11 Approved [1]
------------------------------------------------------------------------------------
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cardiovascular disease DIS2IQDX BA00-BE2Z Phase 3 [2]
------------------------------------------------------------------------------------

References

1 Exenatide FDA Label
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)